Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHEK1 | O14757 | 17/20 | 0.51 |
| ▸ | MMP13 | P45452 | 1/20 | 0.50 |
| ▸ | CDK2AP1 | O14519 | 5/20 | 0.47 |
| ▸ | CFTR | P13569 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | USP2 | O75604 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4213197 | 0.91 | CHEK1 (0.57) | CHEK1CDK2AP1ALDH1A1 | |
| SCHEMBL4210886 | 0.88 | CHEK1 (0.55) | CHEK1CDK2AP1 | |
| SCHEMBL5001091 | 0.86 | CHEK1 (0.55) | CHEK1CDK2AP1ALDH1A1 | |
| SCHEMBL1563805 | 0.82 | CHEK1 (0.71) | CHEK1CDK2AP1 | |
| SCHEMBL4219520 | 0.82 | CHEK1 (0.59) | CHEK1CDK2AP1 | |
| SCHEMBL4994947 | 0.81 | CHEK1 (0.59) | CHEK1CDK2AP1 | |
| SCHEMBL4219757 | 0.81 | CHEK1 (0.59) | CHEK1CDK2AP1 | |
| SCHEMBL5004721 | 0.81 | CHEK1 (0.59) | CHEK1CDK2AP1 | |
| SCHEMBL4994970 | 0.81 | CHEK1 (0.56) | CHEK1CDK2AP1 | |
| SCHEMBL4704937 | 0.79 | CHEK1 (0.55) | CHEK1CDK2AP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2305671-A1 | Thiophene and thiazole derivatives as CHK1 inhibitors | AstraZeneca AB (SE) | 2011-04-06 | — | — | EP | disclosed |